News Releases

ITUS and Serametrix Announce Results of a Blinded Prostate Cancer Study

March 27, 2018

ITUS Announces Issuance of Second Key Cancer Detection Technology Patent

March 26, 2018

ITUS to Present Data from Early Cancer Detection Study Utilizing Artificial Intelligence at the American Association of Immunologists (AAI) Meeting

March 16, 2018

ITUS will Present Data at the American Association of Cancer Research (AACR) Annual Meeting

March 12, 2018

ITUS Corporation to Present at the 2018 Inaugural China Healthcare Investment & Partnering Symposium (CHIPS)

March 9, 2018

ITUS Corporation Forms Alliance with Serametrix Corporation

March 5, 2018

ITUS will Present Artificial Intelligence Powered Early Cancer Detection Technology at the Keystone Symposia Conference - Cancer Immunotherapy: Combinations

February 7, 2018

ITUS Presents Positive Data from its Early Cancer Detection Technology at ASCO-SITC Symposium

January 29, 2018

ITUS Will Present Early Cancer Detection Data at ASCO-SITC Symposium on January 26

January 22, 2018

ITUS Corporation Terminates At-The-Market Offering

December 12, 2017

« Previous
1...
2
3
4
5
6
7
8
9
10
11
...14
Next »

Latest News & Events

Dec 2, 2019

Anixa Biosciences Announces Presentation at the 2019 San Antonio Breast Cancer Symposium

Read More...

Nov 26, 2019

Anixa Biosciences Announces Genesis Research to Join Cchek™ Prostate Cancer Study

Read More...

Nov 22, 2019

Anixa Biosciences Announces Collaboration with Urology Centers of Alabama on Cchek™ Prostate Cancer Study

Read More...

Cancer of the Lung, Breast, Colon, Prostate, and Stomach are the five most prevalent cancers worldwide.